Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / Heparin Induced Thrombocytopenia (HIT-IgG) Assay

Heparin Induced Thrombocytopenia (HIT-IgG) Assay

Brown clotted serum, gel barrier

TestHeparin Induced Thrombocytopenia (HIT-IgG) Assay
Common AbbreviationsHIT, HIT-IgG(PF4-H)
Profile
Clinical IndicationThe HIT screen test combined with a pre-test probability scoring system, known as ‘4Ts’ is a useful aid in the management of HIT suspected patients. A low probability combined with a negative HIT result can exclude the presence of HIT and continue heparin therapy. A weak positivity for the PF4/heparin complex antibodies may indicate that the antibodies are non-platelet activating, while a strong positivity may indicate a higher risk of HIT.
Specimen TypeBlood
Sample TypeBrown clotted serum, gel barrier
Minimum Volume 0.5 - 1.0 mL
Special PrecautionsRefer to Trust policy.
Stability2 hours
Turnaround Time1 hour
LaboratoryYork Hospital
Reference IntervalReference range printed on final report.
LimitationsA positive sample for Rheumatoid Factor may cause a falsely raised HIT IgG levels. Although a positive reaction may indicate the presence of a heparin-associated antibody, the detection of antibodies DOES NOT CONFIRM the diagnosis of heparin-induced thrombocytopenia (HIT), as some patients may have naturally occurring antibodies to PF4.
Additional Information
Internal hospital signage with arrows to Main Reception, Outpatients and Pharmacy

A-Z of Services

A receptionist at an information stand reading some paperwork

Your Visit

Chinese Poland

View all languages >